A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...
Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a Colorado woman allegedly injured by transvaginal mesh products manufactured by American Medical Systems, Inc. The suit was filed on May 21, 2012 in the U.S. District Court for the Northern District of California (Case No. ...
A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).
An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.
Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.
A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...
Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.
Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...
The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...
Three families in western Pennsylvania believe a leading hydraulic fracturing (fracking) company and two water testing labs are conspiring to produce false results that show natural gas drilling is not contaminating their private water wells.
New research has found that bisphosphonate use was tied to a significant increased risk of both atrial fibrillation (AF) and serious AF. Bisphosphonates include Fosamax (alendronate sodium), Reclast and Zometa (zoledronic acid), Boniva (ibandronate sodium), Didronel (etidronate disodium), Actonel (risedronate … Continue reading →
To enable plaintiffs and Merck & Co. Inc. time to work on a potential settlement, a New York federal judge delayed the transfer of hundreds of lawsuits that are part of a multidistrict litigation (MDL) brought over alleged jaw injuries … Continue reading →
Drug giant, Merck, has announced plans to cut 8,500 employees as part of a restructuring meant to increase marketplace competitiveness. Over the next two years, in addition to the massive layoffs, Merck also announced that it would be implementing significant … Continue reading →
A federal judge just ordered hundreds of cases involved in a multidistrict litigation (MDL) brought against Merck & Co. over alleged Fosamax jaw injuries be sent for trial in courts nationwide. Fosamax is Merck’s osteoporosis medication. Drug and device manufacturers … Continue reading →
This week, a New York federal judge denied a request to mandate hundreds of alleged Fosamax victims to substantiate their injuries. Fosamax is manufactured by Merck & Co. U.S. District Judge John Keenan refused the request that would not only … Continue reading →
A study published last month in the American Journal of Gastroenterology suggests that oral bisphosphonate use was associated with a 2.33 percent increased risk of Barretts’ esophagus, a condition that increases the risk of developing esophageal cancer. Barrett’s esophagus, a … Continue reading →
We’ve long been following risks associated with bisphosphonate (BP) drugs like Fosamax, Boniva, and Actonel, which are approved to treat bone-weakening diseases like osteoporosis and Paget’s disease. Cancer patients also often undergo therapy with Aredia, Zometa, and other bisphosphonate drugs … Continue reading →
Merck and Co. was unable to stop doctors from giving expert testimony during the New Jersey-based trial, now under way, regarding osteoporosis drug Fosamax for allegedly causing atypical femur fractures. The federal judge ruled, however, that while the plaintiff’s treating … Continue reading →
The second Fosamax femur fracture trial is underway and involve allegations that Merck’s Fosamax (alendronate) caused femur fractures in some people. The trial began in New Jersey federal court and opening statements are being heard. The lawsuit is one of … Continue reading →
Opening arguments today signaled the start of the second trial charging Merck’s Fosamax with causing femur fractures. In New Jersey federal court the focus was on the case of 58-year-old Bernadette Glynn, who says that the osteoporosis drug is part … Continue reading →